» Articles » PMID: 30659131

Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Abstract

Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions. However, due to inadequate screening protocols in many regions of the world, cervical cancer remains the fourth-most common cancer in women globally. The complete NCCN Guidelines for Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment of cervical cancer. This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations. For recommendations regarding treatment of recurrent or metastatic disease, please see the full guidelines on NCCN.org.

Citing Articles

TIAM2S Operates Multifaced Talents to Alleviate Radiosensitivity, Restrict Apoptosis, Provoke Cell Propagation, and Escalate Cell Migration for Aggravating Radioresistance-Intensified Cervical Cancer Progression.

Chuang P, Su W, Hsieh C, Huang E Cells. 2025; 14(5).

PMID: 40072068 PMC: 11898548. DOI: 10.3390/cells14050339.


In Vitro α/β Ratio Variations in Cervical Cancer, with Consequent Effects on Equivalent Dose in 2 Gy Fraction in High-Dose-Rate Brachytherapy.

Thayer-Freeman C, Washington B, Fabian D, Cheek D, Clair W, Bernard M Adv Radiat Oncol. 2025; 10(3):101725.

PMID: 40062322 PMC: 11889347. DOI: 10.1016/j.adro.2025.101725.


Assessment of Human Papillomavirus Vaccine Knowledge and Attitudes Among Adolescent School Girls in Debre Berhan City, Ethiopia: A Community-Based Cross-Sectional Study.

Ayele S, Tsige A Health Sci Rep. 2025; 8(2):e70506.

PMID: 39995791 PMC: 11848730. DOI: 10.1002/hsr2.70506.


Fertility Sparing Medical Management Options in Gynecologic Cancers.

Kouri A, Darby J Curr Treat Options Oncol. 2025; .

PMID: 39969757 DOI: 10.1007/s11864-025-01299-4.


Health inequality and improvement gap in the prevalence of gynecological cancers among perimenopausal women globally, 1990-2019.

Yang C, Zou J, Luo X, Ou Y, Lin X, Wang X BMC Public Health. 2025; 25(1):590.

PMID: 39939993 PMC: 11823132. DOI: 10.1186/s12889-025-21807-3.